Variable | Frequency (n, %) | Median OS (95% CI) (months) | p-value |
Consultation delay (Months) |
|
|
|
<3 | 6 (7.5%) | 3 (0.29 - 5.70) | 0.005* |
[3 - 6] | 5 (6.3%) | 2.91 (2.39 - 3.13) |
|
[6 - 12] | 3 (3.8%) | 2.91 (0 - 7.58) |
|
>12 | 66 (82.5%) | 1.25 (0.94 - 1.55) |
|
Diagnosis time (Months) |
|
|
|
<1 | 18 (22.5%) | 0.5 (0.03 - 7.99) | 0.101 |
[1 - 2] | 39 (48.75%) | 1.0 (0.05 - 18.92) |
|
[2 - 4] | 22 (27.5%) | 1.67 (0.29 - 9.76) |
|
>4 | 1 (1.25%) | - |
|
Depth of Tumour Invasion |
|
|
|
T1 | 3 (7.1%) | 0.25 (0.11 - 0.38) | 0.096 |
T2 | 22 (27.8%) | 1.16 (0.85 - 1.47) |
|
T3 | 29 (36.7%) | 1.66 (0 - 4.57) |
|
T4 | 25 (32%) | 1.58 (0.73 - 4.3) |
|
Lymph node involvement |
|
|
|
N1 | 11 (25%) | 0.5 (0 - 1.10) | 0.125 |
N2 | 28 (63.6%) | 1.16 (0.73 - 1.59) |
|
N3 | 3 (6.81%) | 4.25 (0 - 9.85) |
|
Distant Metastasis |
|
|
|
M0 | 44 (55.8%) | 1.58 (0.68 - 2.48) | 0.002* |
M1 | 30 (38.2%) | 1.16 (0.73 - 1.53) |
|
Metastasis location |
|
|
|
Absence | 30 (37.4%) | 1.58 (0.68 - 2.48) | 0.002* |
Lung | 18 (22.5%) | 0.25 (0 - 1.13) |
|
Lung. vertebra | 5 (6.2%) | - |
|
Spine (cervical) | 1 (1.2%) | 2.08 - NC |
|
TNM tumour stage |
|
|
|
Stage 1 | 8 (10.0%) | 2.66 (2.08 - 3.24) | 0.001* |
Stage 2 | 27 (33.8%) | 1.66 (1.10 - 2.23) |
|
Stage 3 | 26 (32.5%) | 1.33 (1.12 - 1.54) |
|
Stage 4 | 19 (23.8%) | 0.58 (0 - 1.53) |
|